Strategic Partnerships Opportunity to engage major pharmaceutical and biotech partners through joint research initiatives, given LCRF’s track record of collaborating with Bayer and Boehringer Ingelheim to fund innovative lung cancer research.

Collaborative Grants Leverage LCRF’s established grant programs (Team Science and IASLC-LCRF collaborations) to co-fund translational projects with potential for funding expansions and sponsor branding in early-stage oncology research.

Awareness and Events Align with LCRF’s education and awareness platforms, such as Free to Breathe events and #TogetherSeparately webinars, to create sponsored patient engagement campaigns and community outreach programs.

Genomics Focus Capitalize on LCRF’s genetics study initiatives and partnerships (e.g., with 23andMe) to propose data-driven, precision medicine research collaborations and sponsor-dedicated studies.

Funding Growth Position fundraising services and donor stewardship solutions to support LCRF’s scalable grant portfolio, given their lean size and multi-million dollar grant history with potential for increased revenue impact.